Hechingen, Germany

Marleen Klausmann

This inventor holds 1 USPTO granted patent. Top assignee: Jotec Gmbh. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marleen Klausmann: Innovator in Vascular Prosthesis Technology

Introduction

Marleen Klausmann is a notable inventor based in Hechingen, Germany. She has made significant contributions to the field of medical technology, particularly in the development of vascular prostheses. Her innovative work aims to improve patient outcomes in vascular surgeries.

Latest Patents

Marleen Klausmann holds a patent for a vascular prosthesis designed for blood vessels. This invention features a hollow cylindrical main body made from prosthetic material, which includes proximal and distal openings. The vascular prosthesis is equipped with a stent frame and a first terminal stent ring attached to the prosthetic material at one end. Additionally, it incorporates at least one thread element that reduces the diameter of the respective openings through tensile loading. This innovative design enhances the functionality and effectiveness of vascular prostheses.

Career Highlights

Throughout her career, Marleen has demonstrated a commitment to advancing medical technology. Her work at Jotec GmbH has positioned her as a key player in the development of vascular solutions. With her expertise, she has contributed to the creation of products that significantly impact patient care.

Collaborations

Marleen collaborates with talented professionals in her field, including Jan Ulmer and Oezlem Oeztuerk. These partnerships foster innovation and drive the development of cutting-edge medical technologies.

Conclusion

Marleen Klausmann's contributions to vascular prosthesis technology exemplify her dedication to improving healthcare solutions. Her innovative designs and collaborative efforts continue to shape the future of medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…